Organisation paid for research Program year 2025 Source: CMS Open Payments

Thyroid Endocrinology and Diabetes

Neither a doctor nor a teaching hospital

Research payments

$591,488

1,345 payments

Through program year 2025, Thyroid Endocrinology and Diabetes is reported as receiving $591,488 in research payments, across 1,345 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$7,110	5
2024	Research	$51,526	267
2023	Research	$174,419	195
2022	Research	$141,227	363
2021	Research	$210,362	427
2020	Research	$6,844	88

Breakdown

Who paid Research payments · program years 2020–2025

Novo Nordisk AS $577,693 1,339 payments
Sanofi US Services Inc. $11,095 3 payments
Amgen Inc. $2,700 3 payments

Studies the money was for Research payments · program years 2020–2025

Ex9536-4388 $494,472 507 payments
Nn9535-4801 $71,956 713 payments
A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control $9,125 1 payment
Ex6018-4758 $7,409 48 payments
Nn6435-4697 $3,856 71 payments
Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) $2,700 3 payments
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Basal Insulin Alone or in Addition to Oral Antidiabetes Drugs (OADs) $1,930 1 payment
A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Sever $40 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.